ImageneBio (IMA) Debt Ratio (2023 - 2024)
ImageneBio (IMA) posted Debt Ratio of 0.54 for Q4 2024, up 10772.08% sequentially from 0.0 in Q4 2023, and up 10772.08% YoY from N/an in Q1 2024.
ImageneBio (IMA) Debt Ratio (2023 - 2024) Analysis & Trends
ImageneBio has reported Debt Ratio for 2 years, with the latest figure at 0.54 in Q4 2024.
- Quarterly Debt Ratio rose 10772.08% year-over-year to 0.54 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.54 (up 10772.08% YoY) and the FY2024 annual result came in at 0.54, up 10772.08% from the prior year.
- Debt Ratio rose to 0.54 in Q4 2024 per IMA's latest filing, from 0.0 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.54 in Q4 2024 and troughed at 0.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 0.47 |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.54 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |